DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 1,616 filers reported holding DANAHER CORPORATION in Q3 2020. The put-call ratio across all filers is 1.03 and the average weighting 0.7%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2020 | $16,745,000 | +50.7% | 94,676 | +18.0% | 0.53% | +20.5% |
Q1 2020 | $11,109,000 | -15.6% | 80,246 | -6.4% | 0.44% | +8.8% |
Q4 2019 | $13,162,000 | +12.0% | 85,748 | +5.4% | 0.41% | +1.0% |
Q3 2019 | $11,756,000 | +32.2% | 81,387 | +30.8% | 0.40% | +24.4% |
Q2 2019 | $8,891,000 | +82.0% | 62,203 | +68.2% | 0.32% | +75.1% |
Q1 2019 | $4,884,000 | +17.3% | 36,989 | -8.4% | 0.18% | +0.5% |
Q4 2018 | $4,163,000 | -1.8% | 40,360 | +3.4% | 0.18% | +20.3% |
Q3 2018 | $4,241,000 | +15.3% | 39,024 | +4.7% | 0.15% | +8.5% |
Q2 2018 | $3,679,000 | +3.9% | 37,273 | +3.1% | 0.14% | +1.4% |
Q1 2018 | $3,540,000 | +6.9% | 36,157 | +1.4% | 0.14% | +7.8% |
Q4 2017 | $3,311,000 | +5.9% | 35,671 | -2.1% | 0.13% | -0.8% |
Q3 2017 | $3,126,000 | +5.1% | 36,436 | +3.4% | 0.13% | -5.1% |
Q2 2017 | $2,973,000 | +110.6% | 35,227 | +113.5% | 0.14% | +107.6% |
Q1 2017 | $1,412,000 | +3.1% | 16,502 | -6.0% | 0.07% | -13.2% |
Q4 2016 | $1,369,000 | – | 17,558 | – | 0.08% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
WALTER & KEENAN WEALTH MANAGEMENT LLC /IN/ /ADV | 263,188 | $33,896,000 | 13.46% |
ARTHUR M. COHEN & ASSOCIATES, LLC | 263,188 | $33,896,000 | 13.46% |
Defender Capital, LLC. | 127,230 | $17,610,000 | 12.86% |
Eos Focused Equity Management, L.P. | 53,908 | $7,461,000 | 11.12% |
CORTLAND ASSOCIATES INC/MO | 419,035 | $57,999,000 | 10.88% |
Mirova US LLC | 477,368 | $66,072,000 | 8.75% |
Pactiv General Employee Benefit Trust | 579,300 | $80,181,000 | 8.58% |
Riverstone Advisors, LLC | 57,623 | $7,976,000 | 8.07% |
Eversept Partners, LP | 233,957 | $32,419,197 | 8.06% |
Third Point | 3,570,000 | $494,124,000 | 7.88% |